J Simon Bell


BPharm (Hons), PhD, MPS, Professor and Director, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Vic

Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine

There is currently no robust evidence to support prescribing hydroxychloroquine as a treatment or prophylaxis for COVID-19.

Strategies to promote access to medications during the COVID-19 pandemic

A series of Commonwealth and state initiatives have been enacted to ensure ongoing access to medications during the COVID-19 pandemic.

Current approaches to the pharmacological treatment of Alzheimer’s disease

Medications may be used in conjunction with non-pharmacological treatments to manage cognition, function and behaviour in people with Alzheimer’s disease.

Deprescribing proton pump inhibitors

Evidence supports a patient-centred approach to proton pump inhibitor deprescribing involving stepping down the dose before ceasing or switching to pro re nata use.

Medication management of type 2 diabetes in residential aged care

This article reviews best practice medication management of type 2 diabetes mellitus in residential aged care facilities and highlights practical details for clinicians providing care for residents.

Off-label medicine use: Ethics, practice and future directions

Australia’s new national health priority of Quality Use of Medicine and Medicine Safety should stimulate all stakeholders including consumers to work together to address off-label medicine use.

Strategies to simplify complex medication regimens

Complex regimens are challenging to administer and have been linked to non-adherence, medication errors and hospital admissions.

Undertaking medication review by telehealth

Medication review can be delivered using telehealth during the COVID-19 pandemic to ensure ongoing provision of care to vulnerable patient populations and to minimise risk of infection.